The nation of Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.
This move came to light after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative later clarified that the US was demanding access to health data for research and commercial purposes while refused to guarantee the benefits from future medical innovations.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged further negotiations to secure a deal suitable to all parties so the country's critical HIV treatment initiative can continue.
Wider Implications
This development comes after a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.
As per statements, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our people if a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting frameworks previously set up through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.
"This framework is intended to ensure that when a nation provides its data, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Response
A leading public health body said it acknowledged the official position, but recommended that talks should continue given that much of the nation's Aids initiatives depended on external financing.
"Where technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it added.
The halted deal underscores the complex debate between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.